Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Canis_lupus
|
| gptkbp:affects |
gptkb:Skin
muscles |
| gptkbp:associated_with |
gptkb:Oncology
|
| gptkbp:characteristic |
fatigue
weight loss fever joint pain difficulty swallowing Gottron's papules heliotrope rash muscle inflammation |
| gptkbp:complication |
gptkb:Oncology
gptkb:juvenile_idiopathic_arthritis dysphagia calcinosis |
| gptkbp:condition |
gptkb:systemic_lupus_erythematosus
gptkb:Open_VMS polymyositis mixed connective tissue disease |
| gptkbp:diagnosis |
gptkb:MRI
variable blood tests chronic muscle biopsy potentially life-threatening |
| gptkbp:epidemiology |
more common in adults
more common in children |
| gptkbp:gender |
gptkb:Female
male |
| https://www.w3.org/2000/01/rdf-schema#label |
dermatomyositis
|
| gptkbp:premiered_on |
childhood
adulthood |
| gptkbp:prevalence |
rare
|
| gptkbp:research_focus |
genetic factors
treatment efficacy environmental triggers pathogenesis |
| gptkbp:risk_factor |
stress
age family history smoking gender sunlight exposure certain infections exposure to certain drugs |
| gptkbp:symptoms |
muscle weakness
skin rash |
| gptkbp:treatment |
corticosteroids
immunosuppressants |
| gptkbp:bfsParent |
gptkb:Rituximab
gptkb:rituximab |
| gptkbp:bfsLayer |
5
|